{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:00:37Z","timestamp":1784782837314,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05407-5","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:35:01Z","timestamp":1777955701000},"page":"15919-15940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the PI3K\/Akt\/mTOR and Nrf2 signaling axis with berberine: a novel strategy for attenuating diabetic cardiomyopathy"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-4643","authenticated-orcid":false,"given":"Omnia","family":"Ameen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3689-2648","authenticated-orcid":false,"given":"Eman M.","family":"Sweed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8223-1619","authenticated-orcid":false,"given":"Mona A.","family":"Kora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-7401","authenticated-orcid":false,"given":"Asmaa Abdelkarim","family":"Kenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-2063","authenticated-orcid":false,"given":"Marwa M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-9445","authenticated-orcid":false,"given":"Suzan A.","family":"Khodir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"5407_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111410","volume":"138","author":"MH Abukhalil","year":"2021","unstructured":"Abukhalil MH, Althunibat OY, Aladaileh SH, Al-Amarat W, Obeidat HM, Al-Khawalde AAA, Hussein OE, Alfwuaires MA, Algefare AI, Alanazi KM, Al-Swailmi FK, Arab HH, Mahmoud AM (2021) Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats. Biomed Pharmacother 138:111410","journal-title":"Biomed Pharmacother"},{"key":"5407_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ncrna.2024.01.005","volume":"9","author":"SM Aghaei-Zarch","year":"2024","unstructured":"Aghaei-Zarch SM (2024) Crosstalk between MiRNAs\/lncRNAs and PI3K\/AKT signaling pathway in diabetes mellitus: mechanistic and therapeutic perspectives. Noncoding RNA Res 9:486\u2013507","journal-title":"Noncoding RNA Res"},{"key":"5407_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1590\/0074-02760150295","volume":"110","author":"RA Attia","year":"2015","unstructured":"Attia RA, Mahmoud AE, Farrag HM, Makboul R, Mohamed ME, Ibraheim Z (2015) Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice. Mem Inst Oswaldo Cruz 110:1035\u20131041","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5407_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8194721","volume":"2018","author":"\u015eS Balea","year":"2018","unstructured":"Balea \u015eS, P\u00e2rvu AE, Pop N, Mar\u00edn FZ, P\u00e2rvu M (2018) Polyphenolic compounds, antioxidant, and cardioprotective effects of pomace extracts from Feteasc\u0103 neagr\u0103 cultivar. Oxid Med Cell Longev 2018:8194721","journal-title":"Oxid Med Cell Longev"},{"key":"5407_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","volume":"169","author":"NJ Byrne","year":"2021","unstructured":"Byrne NJ, Rajasekaran NS, Abel ED, Bugger H (2021) Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med 169:317\u2013342","journal-title":"Free Radic Biol Med"},{"key":"5407_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4330\/wjc.v5.i7.261","volume":"5","author":"M Cannillo","year":"2013","unstructured":"Cannillo M, Frea S, Fornengo C, Toso E, Mercurio G, Battista S, Gaita F (2013) Berberine behind the thriller of marked symptomatic bradycardia. World J Cardiol 5:261\u2013264","journal-title":"World J Cardiol"},{"key":"5407_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158369","volume":"25","author":"A Caturano","year":"2024","unstructured":"Caturano A, Galiero R, Vetrano E, Sardu C, Rinaldi L, Russo V, Monda M, Marfella R, Sasso FC (2024) Insulin\u2013heart axis: bridging physiology to insulin resistance. Int J Mol Sci 25:8369","journal-title":"Int J Mol Sci"},{"key":"5407_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05818-z","volume":"15","author":"E Cecerska-Hery\u0107","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Engwert W, Micha\u0142\u00f3w J, Marciniak J, Birger R, Serwin N, Hery\u0107 R, Polikowska A, Goszka M, Wojciuk B, Wi\u015bniewska M, Do\u0142\u0119gowska B (2025) Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications. Sci Rep 15:23605","journal-title":"Sci Rep"},{"key":"5407_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114450","volume":"161","author":"TT Chang","year":"2023","unstructured":"Chang TT, Li SY, Lin LY, Chen C, Chen JW (2023) Macrophage inflammatory protein-1\u03b2 as a novel therapeutic target for renal protection in diabetic kidney disease. Biomed Pharmacother 161:114450","journal-title":"Biomed Pharmacother"},{"key":"5407_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fphar.2020.00042","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G (2020) Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol 11:42","journal-title":"Front Pharmacol"},{"key":"5407_CR11","first-page":"1225","volume":"24","author":"H Cheng","year":"2025","unstructured":"Cheng H, Li X, Wang Y, Deng W, Sun G, Zhang D, Hao J, Liu X (2025) Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review. EXCLI J 24:1225\u20131261","journal-title":"EXCLI J"},{"key":"5407_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.103650","volume":"64","author":"K Das","year":"2020","unstructured":"Das K, Kundu A, Karmakar S, Ghosh M (2020) Novel structured diacylglycerol (DAG) rich oleo formulations activate the Nrf2 pathway and impedes NF-\u03baB translocation to mitigate pre-clinical conditions of hypertension. J Funct Foods 64:103650","journal-title":"J Funct Foods"},{"key":"5407_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040784","author":"B De Geest","year":"2022","unstructured":"De Geest B, Mishra M (2022) Role of oxidative stress in diabetic cardiomyopathy. Antioxidants Basel. https:\/\/doi.org\/10.3390\/antiox11040784","journal-title":"Antioxidants Basel"},{"key":"5407_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13098-023-00998-y","volume":"15","author":"J Deng","year":"2023","unstructured":"Deng J, Yan F, Tian J, Qiao A, Yan D (2023) Potential clinical biomarkers and perspectives in diabetic cardiomyopathy. Diabetol Metab Syndr 15:35","journal-title":"Diabetol Metab Syndr"},{"key":"5407_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3389\/fphys.2018.01042","volume":"9","author":"S Dong","year":"2018","unstructured":"Dong S, Zhang S, Chen Z, Zhang R, Tian L, Cheng L, Shang F, Sun J (2018) Berberine could ameliorate cardiac dysfunction via interfering myocardial lipidomic profiles in the rat model of diabetic cardiomyopathy. Front Physiol 9:1042","journal-title":"Front Physiol"},{"key":"5407_CR16","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1111\/jcmm.16049","volume":"24","author":"S-M Ehteshamfar","year":"2020","unstructured":"Ehteshamfar S-M, Akhbari M, Afshari JT, Seyedi M, Nikfar B, Shapouri-Moghaddam A, Ghanbarzadeh E, Momtazi-Borojeni AA (2020) Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation. J Cell Mol Med 24:13573\u201313588","journal-title":"J Cell Mol Med"},{"key":"5407_CR17","first-page":"495","volume":"12","author":"S Elmorshdy Elsaeed Mohammed Elmorshd","year":"2023","unstructured":"Elmorshdy Elsaeed Mohammed Elmorshdy S, Ahmed SG, Helmy EZ, Abdelbadie SM, Awadalla A, Mahmoud ASH, Elmahdy EHSM, Mohamed HA (2023) Impact of cerium oxide nanoparticles on metabolic, apoptotic, autophagic and antioxidant changes in Doxorubicin-induced cardiomyopathy: possible underlying mechanisms. Rep Biochem Mol Biol 12:495\u2013511","journal-title":"Rep Biochem Mol Biol"},{"key":"5407_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgag031","volume":"78","author":"SR Elnaggar","year":"2026","unstructured":"Elnaggar SR, Sweed EM, Abdou AG, Badr EAE, Eldeeb H, Elbatsh MM (2026) Targeting TGF-\u03b21\/SMAD pathway and MMP-9 activity: the protective role of Vitamin D and Catechin in diabetic cardiomyopathy. J Pharm Pharmacol 78:rgag031","journal-title":"J Pharm Pharmacol"},{"key":"5407_CR19","volume":"15","author":"EO Evbayekha","year":"2023","unstructured":"Evbayekha EO, Nwachukwu EU, Nikravesh E, Rosas V, Onuegbu CA, Egwuonwu OF, Eguagie O, Chioma OE, Agho AV, Samuels KA, Willie A, Nwafor JN, Esene-Akhideno LN, Adigun AO (2023) Berberine for adjunct\/alternative treatment of dyslipidemia: a literature review. Cureus 15:e39261","journal-title":"Cureus"},{"key":"5407_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543\u2013567","journal-title":"Endocr Rev"},{"key":"5407_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37678-w","volume":"13","author":"EAE Farrag","year":"2023","unstructured":"Farrag EAE, Hammad MO, Safwat SM, Hamed S, Hellal D (2023) Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE\/HMGB-1 signaling pathway. Sci Rep 13:11043","journal-title":"Sci Rep"},{"key":"5407_CR22","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"X Feng","year":"2019","unstructured":"Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, \u0160mejkal K, Malan\u00edk M, Sychrov\u00e1 A, Barreca D, Ziberna L, Mahomoodally MF, Zengin G, Xu S, Nabavi SM, Shen AZ (2019) Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics 9:1923\u20131951","journal-title":"Theranostics"},{"key":"5407_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008749","volume":"5","author":"EJ Grossman","year":"2010","unstructured":"Grossman EJ, Lee DD, Tao J, Wilson RA, Park SY, Bell GI, Chong AS (2010) Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One 5:e8749","journal-title":"PLoS One"},{"key":"5407_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2074610","volume":"2021","author":"J Guo","year":"2021","unstructured":"Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ (2021) The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev 2021:2074610","journal-title":"Oxid Med Cell Longev"},{"key":"5407_CR25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z (2018) The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14:1483\u20131496","journal-title":"Int J Biol Sci"},{"key":"5407_CR26","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S0168-8227(11)70019-5","volume":"93","author":"F Iliadis","year":"2011","unstructured":"Iliadis F, Kadoglou N, Didangelos T (2011) Insulin and the heart. Diabetes Res Clin Pract 93:S86\u2013S91","journal-title":"Diabetes Res Clin Pract"},{"key":"5407_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/JEP.S443169","volume":"16","author":"PK Juttla","year":"2024","unstructured":"Juttla PK, Chege BM, Mwangi PW, Bukachi F (2024) Dapagliflozin pretreatment prevents cardiac electrophysiological changes in a diet and streptozotocin induction of type 2 diabetes in rats: a potential new first-line? J Exp Pharmacol 16:123\u2013133","journal-title":"J Exp Pharmacol"},{"key":"5407_CR28","doi-asserted-by":"crossref","unstructured":"Khodir SA, Sweed EM, Badr NM, Zaki NG, Khalil MM, Adel MM (2025) Vit D mitigates metabolic syndrome-induced hepatic damage via antioxidant, anti-inflammatory, and AMPK\/PI3K signaling pathways in rats. Arch Physiol Biochem: 1\u201317","DOI":"10.1080\/13813455.2025.2573343"},{"key":"5407_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","volume":"641","author":"J Kmecova","year":"2010","unstructured":"Kmecova J, Klimas J (2010) Heart rate correction of the QT duration in rats. Eur J Pharmacol 641:187\u2013192","journal-title":"Eur J Pharmacol"},{"key":"5407_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2014.05.020","volume":"1852","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi S, Liang Q (2015) Autophagy and mitophagy in diabetic cardiomyopathy. Biochim Biophys Acta 1852:252\u2013261","journal-title":"Biochim Biophys Acta"},{"key":"5407_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/289264","volume":"2014","author":"Z Li","year":"2014","unstructured":"Li Z, Geng YN, Jiang JD, Kong WJ (2014) Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med 2014:289264","journal-title":"Evid Based Complement Alternat Med"},{"key":"5407_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021132","volume":"24","author":"F Marino","year":"2023","unstructured":"Marino F, Salerno N, Scalise M, Salerno L, Torella A, Molinaro C, Chiefalo A, Filardo A, Siracusa C, Panuccio G, Ferravante C, Giurato G, Rizzo F, Torella M, Donniacuo M, De Angelis A, Viglietto G, Urbanek K, Weisz A, Torella D, Cianflone E (2023) Streptozotocin-induced type 1 and 2 diabetes mellitus mouse models show different functional, cellular and molecular patterns of diabetic cardiomyopathy. Int J Mol Sci 24:1132","journal-title":"Int J Mol Sci"},{"key":"5407_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114128","volume":"158","author":"HMF Mohammad","year":"2023","unstructured":"Mohammad HMF, Galal Gouda S, Eladl MA, Elkazaz AY, Elbayoumi KS, Farag NE, Elshormilisy A, Al-Ammash BB, Hegazy A, Abdelkhalig SM, Mohamed AS, El-Dosoky M, Zaitone SA (2023) Metformin suppresses LRG1 and TGF\u03b21\/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy. Biomed Pharmacother 158:114128","journal-title":"Biomed Pharmacother"},{"key":"5407_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.746382","volume":"8","author":"M Mohan","year":"2021","unstructured":"Mohan M, Dihoum A, Mordi IR, Choy AM, Rena G, Lang CC (2021) Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention. Front Cardiovasc Med 8:746382","journal-title":"Front Cardiovasc Med"},{"key":"5407_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1758-5996-2-29","volume":"2","author":"MD Morsy","year":"2010","unstructured":"Morsy MD, Hassan WN, Zalat SI (2010) Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabetol Metab Syndr 2:29","journal-title":"Diabetol Metab Syndr"},{"key":"5407_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1479164113496441","volume":"10","author":"DC Musial","year":"2013","unstructured":"Musial DC, da Silva J\u00fanior ED, da Silva RM, Miranda-Ferreira R, Lima-Landman MT, Jurkiewicz A, Garc\u00eda AG, Jurkiewicz NH (2013) Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats. Diabetes Vasc Dis Res 10:498\u2013504","journal-title":"Diabetes Vasc Dis Res"},{"key":"5407_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041351","author":"A Och","year":"2022","unstructured":"Och A, Och M, Nowak R, Podg\u00f3rska D, Podg\u00f3rski R (2022) Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease. Molecules. https:\/\/doi.org\/10.3390\/molecules27041351","journal-title":"Molecules"},{"key":"5407_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108604","author":"KL Pan","year":"2023","unstructured":"Pan KL, Hsu YC, Chang ST, Chung CM, Lin CL (2023) The role of cardiac fibrosis in diabetic cardiomyopathy: from pathophysiology to clinical diagnostic tools. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24108604","journal-title":"Int J Mol Sci"},{"key":"5407_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.907757","volume":"13","author":"ML Peng","year":"2022","unstructured":"Peng ML, Fu Y, Wu CW, Zhang Y, Ren H, Zhou SS (2022) Signaling pathways related to oxidative stress in diabetic cardiomyopathy. Front Endocrinol (Lausanne) 13:907757","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5407_CR40","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/bph.15193","volume":"177","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br J Pharmacol 177:3617\u20133624","journal-title":"Br J Pharmacol"},{"key":"5407_CR41","first-page":"300","volume":"31","author":"QY Qiu","year":"2018","unstructured":"Qiu QY, Zhang BL, Zhang MZ, Wu JH, Zhou JW, Liang Z, Zhang YH, Zhang SY (2018) Combined influence of insulin resistance and inflammatory biomarkers on type 2 diabetes: a population-based prospective cohort study of Inner Mongolians in China. Biomed Environ Sci 31:300\u2013305","journal-title":"Biomed Environ Sci"},{"key":"5407_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1535370220956943","volume":"246","author":"AW Qiu","year":"2021","unstructured":"Qiu AW, Cao X, Zhang WW, Liu QH (2021) IL-17A is involved in diabetic inflammatory pathogenesis by its receptor IL-17RA. Exp Biol Med (Maywood) 246:57\u201365","journal-title":"Exp Biol Med (Maywood)"},{"key":"5407_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/948427","volume":"2014","author":"S Raghunathan","year":"2014","unstructured":"Raghunathan S, Tank P, Bhadada S, Patel B (2014) Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. BioMed Res Int 2014:948427","journal-title":"BioMed Res Int"},{"key":"5407_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-023-01755-1","volume":"22","author":"SK Sanganalmath","year":"2023","unstructured":"Sanganalmath SK, Dubey S, Veeranki S, Narisetty K, Krishnamurthy P (2023) The interplay of inflammation, exosomes and Ca(2+) dynamics in diabetic cardiomyopathy. Cardiovasc Diabetol 22:37","journal-title":"Cardiovasc Diabetol"},{"key":"5407_CR45","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovi\u0107","year":"2015","unstructured":"Seferovi\u0107 PM, Paulus WJ (2015) Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J 36:1718\u20131727","journal-title":"Eur Heart J"},{"key":"5407_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","volume":"14","author":"D Song","year":"2020","unstructured":"Song D, Hao J, Fan D (2020) Biological properties and clinical applications of berberine. Front Med 14:564\u2013582","journal-title":"Front Med"},{"key":"5407_CR47","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3889\/oamjms.2022.10861","volume":"10","author":"E Sweed","year":"2022","unstructured":"Sweed E, Sweed D, Galal N, Abd-Elhafiz HI (2022) Dapagliflozin protection against myocardial ischemia by modulating sodium-glucose transporter 2 inhibitor, silent information regulator 1, and fatty acid synthase expressions. Open Access Maced J Med Sci 10:1544\u20131554","journal-title":"Open Access Maced J Med Sci"},{"key":"5407_CR48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/01.ATV.0000012351.63938.84","volume":"22","author":"K Tanaga","year":"2002","unstructured":"Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, Kanno T, Saito Y (2002) Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 22:662\u2013666","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5407_CR49","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/biology12070973","volume":"12","author":"AR Utami","year":"2023","unstructured":"Utami AR, Maksum IP, Deawati Y (2023) Berberine and its study as an antidiabetic compound. Biology 12:973","journal-title":"Biology"},{"key":"5407_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-56","volume":"9","author":"L VanHoose","year":"2010","unstructured":"VanHoose L, Sawers Y, Loganathan R, Vacek JL, Stehno-Bittel L, Novikova L, Al-Jarrah M, Smirnova IV (2010) Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol 9:56","journal-title":"Cardiovasc Diabetol"},{"key":"5407_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmcc.2000.1140","volume":"32","author":"A Vecchini","year":"2000","unstructured":"Vecchini A, Del Rosso F, Binaglia L, Dhalla NS, Panagia V (2000) Molecular defects in sarcolemmal glycerophospholipid subclasses in diabetic cardiomyopathy. J Mol Cell Cardiol 32:1061\u20131074","journal-title":"J Mol Cell Cardiol"},{"key":"5407_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.phymed.2011.11.002","volume":"19","author":"L-H Wang","year":"2012","unstructured":"Wang L-H, Li X-L, Li Q, Fu Y, Yu H-J, Sun Y-Q, Zhang L, Shan H-L (2012) Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats. Phytomedicine 19:206\u2013210","journal-title":"Phytomedicine"},{"key":"5407_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113590","volume":"154","author":"M Wang","year":"2022","unstructured":"Wang M, Jin L, Zhang Q, Zhu W, He H, Lou S, Luo W, Han X, Liang G (2022a) Curcumin analog JM-2 alleviates diabetic cardiomyopathy inflammation and remodeling by inhibiting the NF-\u03baB pathway. Biomed Pharmacother 154:113590","journal-title":"Biomed Pharmacother"},{"key":"5407_CR54","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.18632\/aging.204256","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Duan J, Liao J, Wang Y, Xiao X, Li L, Liu Y, Gu H, Yang P, Fu D, Du J, Li X, Shao M (2022b) LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K\/AKT\/mTOR axis. Aging (Albany NY) 14:6809\u20136828","journal-title":"Aging (Albany NY)"},{"key":"5407_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"JT Warshauer","year":"2020","unstructured":"Warshauer JT, Bluestone JA, Anderson MS (2020) New frontiers in the treatment of type 1 diabetes. Cell Metab 31:46\u201361","journal-title":"Cell Metab"},{"key":"5407_CR56","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","volume":"63","author":"L Wu","year":"2014","unstructured":"Wu L, Parhofer KG (2014) Diabetic dyslipidemia. Metabolism 63:1469\u20131479","journal-title":"Metabolism"},{"key":"5407_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14420","volume":"103","author":"L Wu","year":"2024","unstructured":"Wu L, Meng X-j, Xu T-b, Zhang X-c, Zhou Y, Tong Z-f, Jiang J-h (2024) Berberine attenuates cognitive dysfunction and hippocampal apoptosis in rats with prediabetes. Chem Biol Drug Des 103:e14420","journal-title":"Chem Biol Drug Des"},{"key":"5407_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00210-020-01957-4","volume":"394","author":"ME Youssef","year":"2021","unstructured":"Youssef ME, Abdelrazek HM, Moustafa YM (2021) Cardioprotective role of GTS-21 by attenuating the TLR4\/NF-\u03baB pathway in streptozotocin-induced diabetic cardiomyopathy in rats. Naunyn Schmiedebergs Arch Pharmacol 394:11\u201331","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5407_CR59","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1111\/jcmm.15123","volume":"24","author":"M Zhang","year":"2020","unstructured":"Zhang M, Wang X, Liu M, Liu D, Pan J, Tian J, Jin T, Xu Y, An F (2020) Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K\/Akt\/mTOR signalling pathway in diabetic cardiomyopathy. J Cell Mol Med 24:4612\u20134623","journal-title":"J Cell Mol Med"},{"key":"5407_CR60","first-page":"479","volume":"17","author":"W Zheng","year":"2019","unstructured":"Zheng W, Li D, Gao X, Zhang W, Robinson BO (2019) Carvedilol alleviates diabetic cardiomyopathy in diabetic rats. Exp Ther Med 17:479\u2013487","journal-title":"Exp Ther Med"},{"key":"5407_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.750382","volume":"9","author":"H Zheng","year":"2021","unstructured":"Zheng H, Zhu H, Liu X, Huang X, Huang A, Huang Y (2021) Mitophagy in diabetic cardiomyopathy: roles and mechanisms. Front Cell Dev Biol 9:750382","journal-title":"Front Cell Dev Biol"},{"key":"5407_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166989","volume":"1870","author":"H Zheng","year":"2024","unstructured":"Zheng H, Li W, Huang G, Zhu H, Wen W, Liu X, Sun L, Ma T, Huang X, Hu Y, Huang Y (2024) Secreted frizzled-related protein 2 ameliorates diabetic cardiomyopathy by activating mitophagy. Biochim Biophys Acta Mol Basis Dis 1870:166989","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5407_CR63","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.3390\/ijms21124278","volume":"21","author":"M Zych","year":"2020","unstructured":"Zych M, Wojnar W, Kielanowska M, Folwarczna J, Kaczmarczyk-Sedlak I (2020) Effect of Berberine on glycation, aldose reductase activity, and oxidative stress in the lenses of streptozotocin-induced diabetic rats in vivo-a preliminary study. Int J Mol Sci 21:4278","journal-title":"Int J Mol Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05407-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:02:15Z","timestamp":1784779335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5407"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05407-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of the research was conformed from the Research Ethics Committee in the Faculty of Medicine, Menoufia University, Egypt with IRB No 3\/2024 BIO13-2.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}